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drugs 
Abbott Laboratories 
Any drug company would covet a 
machine that identifies the building 
blocks for the perfect drug and then 
indicates how the building blocks 
should be joined together to create 
that drug. Perhaps, say researchers at 
Abbott Laboratories, that machine 
has been present in most 
pharmaceutical companies all along. 
A new method dubbed SAR by 
NMR (structure-activity 
relationships by nuclear magnetic 
resonance spectroscopy) uses an 
NMR machine to screen through 
thousands of building blocks, 
identifying those that bind to the site 
of interest in a protein. These weak 
binders are then linked together to 
create powerful inhibitors that bind 
at nanomolar concentrations. 
The strong from the weak 
Researchers in both academia and 
industry are excited by the method, 
published by Stephen Fesik’s group 
in Science late last year. “Apparently 
every pharmaceutical company in the 
universe with an NMR department 
is jumping on this,” says Michael 
Rosen of Sloan Kettering Cancer 
Research Center. 
“It combines screening with an 
aspect of thermodynamics that is 
very elegant,” continues Rosen. 
First, when the two weak binders are 
linked, their free energies of binding 
are additive, so the new binding 
affinity is the product of the two old 
binding affinities. And second, 
explains Fesik, “you can get a bigger 
boost even than that” because the 
linking removes one of the negative 
entropy terms. That boost that can 
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convert micromolar binders to 
nanomolar binders. 
Fesik used one of the strengths of 
NMR, its ability to identify weak 
binding interactions, to find the 
micromolar binders. The Abbott 
team used an IsN-labeled target (in 
this case FK506-binding protein 
(FKBP)), eliminating the 
background that usually arises from 
non-specific binding of labeled 
ligands. The ligands that bound the 
target altered the electronic 
environment around the protein 
amides. This was detected using a 
standard two-dimensional (ZD) 
NMR method called heteronuclear 
single-quantum correlation 
spectroscopy (HSQC; see box). 
The testing process had a 
decimal theme: ten days to test 
10,000 ligands in batches of ten. 
When a positive pool was identified, 
each member of that pool was tested 
individually. Once the team had 
identified a molecule that bound 
FKBP, they repeated the process to 
find another that bound nearby. This 
latter test was conducted in the 
presence of the first binder, thus 
ensuring that the two final molecules 
would not overlap unfavorably. 
To determine how to link the two 
molecules, Fesik used computer 
modeling of the NMR-derived 
structure of FKBP with the 
untethered ligands. The best of the 
five final products had a binding 
constant (KJ of 19 nhl, very much 
better than the Kds of the starting 
compounds (2 FM and 100 FM). 
The genesis of an idea 
The conceptual parent of SAR by 
NMR is combinatorial chemistry, 
which involves the reaction of large 
numbers of building blocks with each 
other in all possible combinations, 
either in mixtures or massively 
parallel syntheses. The new method 
also relies on the combination of small 
molecule building blocks, but the 
building blocks are selected out by 
the NMR experiment. 
Thus, even though a huge ‘virtual’ 
library is theoretically sampled, the 
number of synthetic reactions is 
reduced from thousands to a handful. 
This means faster development 
times, even as more complex 
chemistries are used. The diversity of 
the building blocks is limited only by 
the need for millimolar solubility. 
The idea of using NhlR to probe 
small molecule interactions with 
proteins is not new. A number of 
groups have added single, simple 
organic chemicals to proteins and 
used NMR to determine where the 
chemical interacts (usually weakly) 
with the protein. Such information 
can give clues as to what chemical 
shapes fit well into particular protein 
pockets. What Fesik has done, says 
Ad Bax of the National Institutes of 
Health, is “put two and two together 
and come up with a realistic screening 
procedure.” 
Experiment or compute 
If one extreme of drug discovery is 
purely experimental combinatorial 
chemistry, its polar opposite is 
computational drug design. Using a 
computer to predict which small 
molecules will bind a protein has 
proven difficult for a number of 
reasons. It is difficult to predict both 
the extent of entropy effects (e.g., the 
energetic cost when the mobility of a 
hgand decreases upon binding, or the 
energetic gain when water molecules 
are liberated by ligand binding), and 
whether ligands or proteins will 
. undergo conformational changes upon 
binding. And to explore enough 
molecules, the forces involved in 
binding have to be simplified. But the 
most troubling variable is the 
treatment of water and ions. 
“The others can all be addressed 
in one manner or another,” says Irwin 
Kuntz of the University of California 
at San Francisco. A lack of 
experimental data means that this 
starting point is lacking for water 
placement. “It’s unclear whether you 
include the water as part of the 
protein and try and come up with 
ligands for it,” says Fesik, “or do you 
take it out and make a ligand that 
would displace it.” 
232 Chemistry & Biology 1997, Vol 4 No 3 
“The NMR experiment gives you 
an experimental result whereas the 
computational approach gives you a 
hypothesis,” acknowledges Kuntz. 
The advantages are not all with the 
NMR method, however. The speed 
of computational screening, which 
requires only fractions of a second 
per sample, cannot be beaten. 
Changing drug discovery 
Although the NMR divisions of drug 
companies were adept at generating 
three-dimensional structures of 
proteins, they needed new ways to 
use these structures. In the past, 
NMR was only brought in at the 
later stages of drug development, to 
see exactly how a lead was binding 
and so suggest modifications. In the 
early stages, biological testing 
selected leads from amongst the 
compounds made by medicinal 
chemists. “Now,” says Rosen, “the 
spectroscopists can generate their 
own leads.” 
In academia, Gerhard Wagner of 
Harvard Medical School sees the 
potential for a lot of collaborations. 
For each experiment the NMR 
structure of the target must be 
solved and an appropriate library of 
building blocks must be made or be 
otherwise available. “For a single 
laboratory that’s pretty unrealistic,” 
says Wagner. But in a collaboration 
the academic laboratory could 
contribute one element, and finish 
up with a selective inhibitor 
to use in further basic research. 
Kuntz is looking forward to 
collaborations in which 
computational techniques are used 
to improve on the existing NMR 
method. The speed of computa- 
tional methods means that they can 
be used to screen through huge 
libraries and the results can be used 
in selecting building blocks for the 
NMR experiment. “These are 
potentially complementary 
approaches,” he says. 
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A Beginner’s Guide to NM R 
NMR works because some nuclei act like 
tiny magnets. The basis for this magnetism 
is a pair of properties that protons and 
neutrons share with electrons: they have 
intrinsic spin and they are distributed in 
discrete orbitals. Protons and neutrons both 
pair in orbitals, and the two members of the 
pair have opposite spin and cancel each 
other out. But if either protons or neutrons 
are unpaired in an orbital (as happens in ‘H 
and 13C, but not 12C), the nucleus as a 
whole has spin. As these spinning nuclei are 
charged, they generate a magnetic field. 
When a magnetic field is externally 
applied to a molecule, more of the nuclei in 
the molecule align with the magnetic field 
than against it, generating a bulk 
magnetization in the direction of the 
external field. As with a gyroscope, which 
is spinning but affected by a gravitational 
field, the combination of spin and the 
magnetic field causes the nuclei to rotate 
(or, more correctly, precess) around the 
direction of the external field. 
Describing individual atoms: 1 D spectra 
An NMR experiment starts with a 
radiofrequency (rf) pulse that generates a 
magnetic field perpendicular to the external 
magnetic field. This rotates the nuclei and 
therefore their bulk magnetization, and the 
change is detected by a receiver coil. The 
signal oscillates at the rate at which the 
nucleus is spinning. 
The signal is useful because the 
frequency of oscillation varies for different 
nuclei (e.g., spinning hydrogen and 
nitrogen atoms have different angular 
momenta). This frequency is modified 
depending on how well the nucleus is 
shielded (by electrons, for example) from 
the applied magnetic field; this value is 
termed the chemical shift. For example, an 
electron-withdrawing group nearby will 
change the chemical shift. 
In its original form, NMR involved a 
continuous scan over different 
radiofrequencies to perturb different nuclei 
individually. This time-consuming approach 
has been replaced by pulse NMR: one 
short, strong pulse, which excites all nuclei 
simultaneously. Pulse NMR is not unlike 
hitting a bell instead of playing a scale to 
find which note the bell resonates to. 
The single pulse gives a complicated 
output of many overlapping waves. 
Fortunately, a Fourier transform, in a flurry 
of almost incomprehensible mathematics, 
can be used to do two important things. It 
converts the time dimension into 
frequency, and it separates the overlapping 
waves into individual signals, one per 
nucleus. The result is a one-dimensional 
(1 D) spectrum of frequency versus intensity. 
Connecting atoms: 2D spectra 
The simple, 1 D spectra described above 
tell you a lot about the environment each 
atom finds itself in. But for structure 
determination, spectroscopists need two- 
dimensional (2D) spectra to give them 
information about relationships between 
atoms. The atoms are grouped, or 
correlated, by transferring magnetization 
between atoms. 
The magnetization transfer is a 
complicated process involving quantum 
properties of the intervening bond, but two 
simple models are helpful. First, taking 
each nucleus as a magnet, we know that 
two magnets that are close to each other 
will affect each others behavior. 
Second, the two nuclei can be modeled 
as two pendulums, and the bond between 
them represented by a stiff rod. When an 
initial pulse sets one of the pendulums in 
motion, the energy in this pendulum is 
gradually transferred to the other, which 
eventually takes over all the motion. 
In the method used by Fesik’s group, 
the first pulse is directed at the protons in 
the (ligand-free) protein. For those protons 
that are in amide groups, the change in 
magnetization can transfer along the bonds 
to the amide nitrogens. A series of pulses is 
used to transfer magnetization back to the 
proton, and the proton signal is recorded. 
These transfers are useful because the 
signal does not returned unchanged. The 
chemical shift of the nitrogen is now 
superimposed on that of the proton. As the 
length of time between magnetization 
transfers is varied over multiple experiments, 
the nitrogen chemical shift oscillates on top 
of the proton chemical shift. The separation 
of these two values gives the coordinates of 
a unique point on a 2D plot, where the two 
axes represent the chemical shifts of the 
proton and nitrogen, respectively. 
Determining structure and ligand binding 
The amide peaks are assigned to specific 
residues in the protein by continuing the 
transfer of magnetization along the protein 
backbone, one bond at a time. Modification 
of the signal from the originating nucleus 
by neighboring nuclei allow the neighbors 
to be correlated. The direction of transfer is 
defined by pulses whose frequency targets 
only the originating and destination nuclei; 
the same pulses effectively cancel out any 
transfer in the other direction along the 
protein chain. 
When a ligand binds to the protein 
target, it alters the electronic environment 
around nearby residues. This shows up as 
differences in the spectrum only at those 
few residues, thus indicating both the 
occurrence of binding and its location. 
